Thursday, January 23, 2020
Tel: 561.316.3330
Breaking Medical Device Industry News
Home Aesthetics Biomedical Inc.

Aesthetics Biomedical Inc.

    Aesthetics Biomedical Introduces Vivace 3D Precision – An Optimized, Layered, and Precise Approach to RF Microneedling Treatments

    Aesthetics Biomedical Inc.
    3/20/19: A layered treatment technique that further optimizes the clinical outcomes and patient experience that has made the Vivace RF Microneedle one of the fastest growing minimally-invasive skin treatments.
    LEARN MORE

    RECENT COMMENTS

    Martha Lynn on Medtronic Announces FDA Submission for InterStim™ Micro Neurostimulator and SureScan™ MRI Leads
    Prof Sherif Sultan on Perfect AAA EVAR Stent Has Not Been Designed or Produced: All Current AAA EVAR Devices are Obsolete
    Khaled mohamed fekry saleh on Perfect AAA EVAR Stent Has Not Been Designed or Produced: All Current AAA EVAR Devices are Obsolete
    Medical Device News Magazine on Neurolief’s Relivion™ Digital Therapeutics Brain Neuromodulation Technology Featured at Headache Symposium in Israel
    Paula on Neurolief’s Relivion™ Digital Therapeutics Brain Neuromodulation Technology Featured at Headache Symposium in Israel
    Helen on New Study Validates Rigorous Safety Measures Needed To Reduce Mercury Exposure During Dental Amalgam Filling Removal
    JP on Groundswell Pushing FDA to Stop Mercury Amalgam Use in Children: Op-Ed
    Teresa Franklin on Groundswell Pushing FDA to Stop Mercury Amalgam Use in Children: Op-Ed
    Cynthia Easter on Groundswell Pushing FDA to Stop Mercury Amalgam Use in Children: Op-Ed
    Rob Abbot on Groundswell Pushing FDA to Stop Mercury Amalgam Use in Children: Op-Ed
    Teresa Franklin on Groundswell Pushing FDA to Stop Mercury Amalgam Use in Children: Op-Ed
    Eugenia McGrath on Groundswell Pushing FDA to Stop Mercury Amalgam Use in Children: Op-Ed
    Helen on Groundswell Pushing FDA to Stop Mercury Amalgam Use in Children: Op-Ed
    Molly Hauck on Groundswell Pushing FDA to Stop Mercury Amalgam Use in Children: Op-Ed
    Eric Uram on Groundswell Pushing FDA to Stop Mercury Amalgam Use in Children: Op-Ed
    Patrick on Groundswell Pushing FDA to Stop Mercury Amalgam Use in Children: Op-Ed
    Michael Bender on Groundswell Pushing FDA to Stop Mercury Amalgam Use in Children: Op-Ed
    ganka on New Cochlear™ Nucleus Sound Processor® Profile™ Plus Series Cochlear Implant and Nucleus 7 Sound Processor Receive FDA Approval
    Airtech Equipment Pte Ltd on Leaf Healthcare, Inc. Acquired by Smith & Nephew
    Harry on Experts Discuss How They’ve Adopted TransCarotid Artery Revascularization (TCAR)
    Juan C Parodi on From Resistance to Standard of Care: Gaining Acceptance for Technology to Prevent Stroke
    Bergantini Hélio on First Patient Treated in First-in-Man Study of Deep Vein Thrombosis Treatment Designed to Remove Wall-Adherent Clot in Single Session, without Thrombolytic Drugs
    Osama on First Patient Treated in First-in-Man Study of Deep Vein Thrombosis Treatment Designed to Remove Wall-Adherent Clot in Single Session, without Thrombolytic Drugs
    dr.ashwin bhammar on From Resistance to Standard of Care: Gaining Acceptance for Technology to Prevent Stroke
    Ilene on From Resistance to Standard of Care: Gaining Acceptance for Technology to Prevent Stroke
    Amy Lewis on From Resistance to Standard of Care: Gaining Acceptance for Technology to Prevent Stroke
    M Subramaniam on Negative Abdominal Aortic Aneurysm NICE Guidelines is A Step Backward: Don’t be Fooled by Them
    Harry on Negative Abdominal Aortic Aneurysm NICE Guidelines is A Step Backward: Don’t be Fooled by Them
    Sherif on Negative Abdominal Aortic Aneurysm NICE Guidelines is A Step Backward: Don’t be Fooled by Them
    © Medical Device News Magazine, a division of PTM Healthcare Marketing, Inc.